Aurinia Pharmaceuticals Inc. (AUPH)
收市後：
| 前收市價 | 4.99 |
| 開市 | 4.98 |
| 買盤 | 5.00 x 100 |
| 賣出價 | 5.06 x 900 |
| 今日波幅 | 4.92 - 5.06 |
| 52 週波幅 | 4.71 - 12.43 |
| 成交量 | |
| 平均成交量 | 2,105,667 |
| 市值 | 730.321M |
| Beta 值 (5 年，每月) | 1.38 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.54 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 11.29 |
Insider Monkey11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]
Insider MonkeyAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript February 15, 2024 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.18. AUPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to Aurinia […]
ZacksAurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of -5.56% and 3.52%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
